Literature DB >> 4018038

2-Nitroimipramine: a photoaffinity probe for the serotonin uptake/tricyclic binding site complex.

L P Wennogle, R A Ashton, D I Schuster, R B Murphy, L R Meyerson.   

Abstract

[3H]2-Nitroimipramine ([3H]2-NI), a compound with high affinity for the serotonin uptake system, is shown to be an effective photoaffinity probe which incorporates covalently into membrane homogenates prepared from human platelets, as well as rat brain and liver. In all cases, [3H]2-NI preferentially incorporated into a minor membrane component of 30 kd protein, as determined by SDS-polyacrylamide gel electrophoresis and subsequent fluorography. A number of selective and general serotonin uptake inhibitors quantitatively chased labeling of the 30-kd band at nanomolar concentrations. Pharmacological characterizing agents unrelated to the serotonin uptake system generally had little effect on labeling. In platelet membranes, a broad band of approximately 35-kd protein was also labeled by [3H]2-NI, but this labeling was not inhibited by any of the selective serotonin uptake blockers. Interestingly, serotonin itself increased incorporation into the 30-kd band and selectively decreased labeling of the 35-kd band. Photolytic incorporation into the 30-kd band was of high affinity, saturable, and Scatchard analyses of irreversible labeling were linear. In contrast, Scatchard transformations of [3H]2-NI equilibrium binding saturation isotherms were markedly curvilinear. Cross-linking unlabeled 2-NI to intact platelets, followed by extensive dialysis, decreased the maximal velocity (Vmax) of platelet serotonin uptake, but did not alter the affinity (Km) of serotonin for its transport site. These results are noteworthy since current theories implicate prejunctional allosteric interactions between serotonin and imipramine at serotonergic synapses.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4018038      PMCID: PMC554287          DOI: 10.1002/j.1460-2075.1985.tb03726.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  52 in total

1.  Inhibitory effect of clomipramine and related drugs on serotonin uptake in platelets: more complicated than previously thought.

Authors:  O Lingjaerde
Journal:  Psychopharmacology (Berl)       Date:  1979-03-28       Impact factor: 4.530

2.  Blockade of presynaptic alpha-receptors and of amine uptake in the rat brain by the antidepressant mianserine.

Authors:  P A Baumann; L Maître
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Demonstration of specific "high affinity" binding sites for [3H] imipramine on human platelets.

Authors:  S M Paul; M Rehavi; P Skolnick; F K Goodwin
Journal:  Life Sci       Date:  1980-03-24       Impact factor: 5.037

5.  High- and low-affinity binding of [3H]imipramine in mouse cerebral cortex.

Authors:  M E Reith; H Sershen; D Allen; A Lajtha
Journal:  J Neurochem       Date:  1983-02       Impact factor: 5.372

6.  Molecular mechanisms in the action of imipramine.

Authors:  E Costa; D M Chuang; M L Barbaccia; O Gandolfi
Journal:  Experientia       Date:  1983-08-15

7.  Regional distribution of [3H]imipramine binding in rat brain.

Authors:  M Palkovits; R Raisman; M Briley; S Z Langer
Journal:  Brain Res       Date:  1981-04-06       Impact factor: 3.252

8.  Uptake of 14C-5-hydroxytryptamine by human and rat platelets and its pharmacological inhibition. A comparative kinetic analysis.

Authors:  M Wielosz; M Salmona; G de Gaetano; S Garattini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-12       Impact factor: 3.000

Review 9.  High-affinity 3H-imipramine binding: a new biological marker in depression.

Authors:  S Z Langer; E Zarifian; M Briley; R Raisman; D Sechter
Journal:  Pharmacopsychiatria       Date:  1982-01

10.  Modulation of neuronal serotonin uptake by a putative endogenous ligand of imipramine recognition sites.

Authors:  M L Barbaccia; O Gandolfi; D M Chuang; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

View more
  6 in total

1.  The state of the serotonin transporter protein in the platelets of patients with somatoform [correction of somatiform] disorders.

Authors:  A R Belous; S Ramamoorthy; R D Blakely; M I Factor; A M Dupin; A B Katasonov; R H Lozier; A G Beniashvili; M A Morozova; O S Brusov
Journal:  Neurosci Behav Physiol       Date:  2001 Mar-Apr

2.  Clickable photoaffinity ligands for the human serotonin transporter based on the selective serotonin reuptake inhibitor (S)-citalopram.

Authors:  Nageswari Yarravarapu; Laura Geffert; Christopher K Surratt; Michael Cascio; David J Lapinsky
Journal:  Bioorg Med Chem Lett       Date:  2018-09-22       Impact factor: 2.823

Review 3.  Platelets as a model for neurones?

Authors:  M Da Prada; A M Cesura; J M Launay; J G Richards
Journal:  Experientia       Date:  1988-02-15

4.  (125I)iodoazidococaine, a photoaffinity label for the haloperidol-sensitive sigma receptor.

Authors:  J R Kahoun; A E Ruoho
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

5.  Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-Citalopram.

Authors:  Vivek Kumar; Nageswari Yarravarapu; David J Lapinsky; Danielle Perley; Bruce Felts; Michael J Tomlinson; Roxanne A Vaughan; L Keith Henry; John R Lever; Amy Hauck Newman
Journal:  J Med Chem       Date:  2015-07-08       Impact factor: 7.446

6.  Azidobupramine, an Antidepressant-Derived Bifunctional Neurotransmitter Transporter Ligand Allowing Covalent Labeling and Attachment of Fluorophores.

Authors:  Thomas Kirmeier; Ranganath Gopalakrishnan; Vanessa Gormanns; Anna M Werner; Serena Cuboni; Georg C Rudolf; Georg Höfner; Klaus T Wanner; Stephan A Sieber; Ulrike Schmidt; Florian Holsboer; Theo Rein; Felix Hausch
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.